Adding To Their Expert Team, Albert Labs Announces The Formation And Chairs Of Its Two Advisory Boards.

Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to a company pursuing psilocybin-based therapies May 25TH , 2021 - VANCOUVER, BRITISH COLUMBIA, Albert Labs,…

Continue ReadingAdding To Their Expert Team, Albert Labs Announces The Formation And Chairs Of Its Two Advisory Boards.

Albert Labs Appoints Mackie Research As Lead Agent For Private Placement Of Proceeds Up To $4 Million Pre-RTO

Albert Labs leverages Real-World Evidence (RWE) studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet needs. April 14TH , 2021 - VANCOUVER, BRITISH…

Continue ReadingAlbert Labs Appoints Mackie Research As Lead Agent For Private Placement Of Proceeds Up To $4 Million Pre-RTO

MEC signs RTO definitive agreement to acquire albert labs, a European psychedelic drug researcher & developer

Albert Labs leverages Real-World Evidence (RWE) studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet needs. MARCH 5th , 2021-VANCOUVER, BRITISH COLUMBIA, ME Resource…

Continue ReadingMEC signs RTO definitive agreement to acquire albert labs, a European psychedelic drug researcher & developer

MEC announces letter of intent to acquire Albert Labs, a European psychedelic drug researcher & developer

Albert Labs leverages Real-World Evidence (RWE) studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet needs. January 5, 2021-VANCOUVER, BRITISH COLUMBIA, ME Resource Corp. (“MEC” or…

Continue ReadingMEC announces letter of intent to acquire Albert Labs, a European psychedelic drug researcher & developer